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Therapeutic Ultrasound Angioplasty: The Risk of Arterial
Perforation. An In Vitro Study
Mark P. Wylie, Garrett B. McGuinness, and Graham P. Gavin
Abstract— The use of therapeutic ultrasound delivered via
small diameter wire waveguides may represent an emerging
minimally invasive approach in the treatment of chronic total
occlusions (CTOs), calcified and fibrous plaques. The distal-tip
mechanical vibrations (typically 0-210 µm peak-to-peak) have
been reported to debulk rigid calcified and fibrous tissues while
healthy elastic arterial tissue remains largely unaffected. The
risk of arterial (healthy tissue) perforation with energized
waveguides is not fully understood. An ultrasonic apparatus
capable of delivering a range of wire waveguide distal-tip
displacements, up to 80 µm peak-to-peak (p-p), at an
operational frequency of 22.5 KHz (+/- 6%) has been developed.
For three distal-tip displacement settings (32, 50 and 80 µm p-p)
with 1.0 mm diameter waveguides, the force required to
perforate healthy porcine aortic tissue was experimentally
determined.
The results show a distinct two stage perforation, thought to
be the result of different mechanical properties of the layers in
the arterial wall. The average maximum force (N) required to
cause perforation with the 1.0 mm diameter ultrasonic
waveguide activated at the three settings was experimentally
determined to be 2.7 N (32 µm p-p), 2.6 N (50 µm p-p) and 2 N
(80 µm p-p). The force required to cause perforation of the
tissue with no ultrasound was found to be approximately 4 N.
These results highlight that when ultrasound energy is applied
to the waveguide, less force is required to perforate healthy
arterial tissue. This reduction in perforation force is more
pronounced at higher ultrasonic displacements, similar to those
reported in clinical studies for the effective removal of diseased
calcified and fibrous plaques.

C

I. INTRODUCTION

ardiovascular diseases (CVDs) are the number one
cause of death globally [1]. Atherosclerosis is an intimal
lesion that effects large and medium sized muscular arteries
(such as coronary, iliac and femoral) and also large elastic
arteries (such as aorta). It is a gradual chronic cardiovascular
disease and is the most common cause of acute myocardial
infarction [2], [3].
This disease begins with deposits of fatty substances
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(lipoproteins), cholesterol and cellular waste on the arterial
endothelium but may progress to a fibro-calcific plaque. The
majority of atherosclerotic lesions can be treated by
minimally invasive dilation procedures such as balloon
angioplasty and stent implantation.
These procedures often require that the lesion is initially
crossed by a guidewire, a thin wire that acts as a rail for the
dilation catheter. Plaques resulting in a near or totally
occluded artery are known as chronic total occlusions
(CTOs) and are often associated with dense calcifications.
They can be identified in approximately 20% of all patients
undergoing angioplasty and are challenging to classic
dilation procedures that require prior guidewire crossing [4].
The limitations of standard dilation procedures mentioned
have propagated an intensive search for adjuncts to balloon
angioplasty and alternative therapies [5]-[8].
One such approach involves the use of low frequency (2045 kHz) high power therapeutic ultrasonic energy delivered
via small diameter wire waveguides. This form of energy
develops a longitudinal standing wave in the wire waveguide
and can result in distal-tip displacements up to 210µm peakpeak (p-p). This type of minimally invasive surgery has
gained regulatory approval in recent years (2007/8) in the
United States and Europe for treatment of CTOs [9]. It is
reported that this form of energy can be useful for the
treatment of CTOs by disrupting and ablating rigid calcified
and fibrous plaque tissue while the healthy elastic arterial
tissue in the region remains largely unaffected [10].
Using ultrasound in this manner may affect plaque by a
number of ablation or disruption mechanisms. Direct
mechanical agitation, cavitation, acoustic streaming and
pressure components have all been reported [11], [12].
While the effects of ultrasound on rigid calcified and
fibrous tissues have been the focus of the majority of studies
the impact that this form of energy delivery has on
surrounding healthy tissue is less well known, including
adverse effects such as the risk of arterial perforation.
Chikada [13] conducted a number of experiments on
diseased and healthy tissue using a 2.5 mm probe at an
operational frequency of 24 kHz. This study focused on the
ablation and removal of diseased plaques and demonstrated
incidents of perforation of the surrounding healthy tissue at
greater distal-tip displacements. The forces required to
perforate the various plaque types were not reported while
probe dimensions and amplitudes were not representative of
minimally invasive ultrasonic angioplasty devices.

As part of this work, the goal was to experimentally
determine the forces required to perforate healthy porcine
aortic tissue using waveguide distal-tip geometries and
displacements similar to those reported in clinical studies
[9]-[13].
II. METHODOLOGY
A. Ultrasonic Wire Waveguide Apparatus
An experimental ultrasonic apparatus was developed that
can transmit ultrasonic energy through 1.0 mm diameter
Nickel-Titanium (NiTi) waveguides with rounded distal tips.
The frequency of operation was experimentally determined,
as part of previous work, to be 22.5 KHz (+/- 6%) with
achievable distal tip displacements of between 0 - 100µm pp depending on power input level [14],[15]. These ultrasonic
displacement measurements were made with an optical
microscope and vision analysis software.
B. Experimental Rig Development
A test rig capable of advancing the ultrasonic waveguide
vertically in a controlled manner was designed and
developed. The ultrasonic converter and acoustic horn were
secured vertically to a stepper motor lead screw assembly.
The waveguide could be advanced at constant feed-rates
between 0.05 and 1.5 mm/s, controlled via a stepper drive
card.
The rig facilitated the securing of tissue samples in a
cantilever beam assembly which had a half-bridge
temperature compensation strain gauge arrangement capable
of determining the force applied on the sample. The beam
and tissue were submerged in a 15 L thermostatic bath of
water at 37 0C. The programming environment and
hardware used to control the various instruments and
acquisition of data was LabView© and National
Instruments© PCI6221 DAQ. A schematic of the
experimental set up is shown below, see Figure 1.

Fig. 1. Schematic of experimental rig with ultrasonic angioplasty
apparatus, cantilever arrangement, thermostatic tank and data acquisition
environment

Fig. 2. Picture of experimental rig for tissue testing using ultrasound
transmitted via NiTi wire wave guides.

Fig. 3. Picture of cantilever beam tissue holder and strain gauge
arrangement.

C. Tissue Preparation
Approximately 150 mm length of porcine aortic tissue was
harvested, refrigerated and prepared for testing less than 24
hours after death. A single aortic section was cut into twelve
sample sizes of 5 mm × 20 mm. Connective tissue was also
removed from arteries outer wall. The tissue was stored in a
saline solution at 370C for approximately one hour prior to
testing.
D. Experimental Protocol
To test the force required to perforate the arterial tissue in
vitro, the 1.0 mm diameter waveguide was advanced through
the samples (at 370C) both with and without ultrasonic
activation. All experiments were conducted with a constant
feed-rate of 0.5 mm/s.
For the experiments with ultrasonic waveguide activation
the ultrasound was operated in continuous mode at 22.5 kHz.

Three different power settings were tested corresponding to
distal-tip displacements of 32, 50 and 80 µm p-p.
III. RESULTS AND DISCUSSION
A total of 12 porcine aorta tissue samples were tested.
Three samples were subjected to perforation with no
ultrasonic energy applied to the waveguide and nine samples
(three per power setting level) with the ultrasonic activation.
Figure 4 shows examples of the experimental perforation
profiles achieved for the waveguide with no ultrasound
activation and for the three power settings. The results show
a two stage penetration, both with and without ultrasound.
This may be associated with the composition of the aortic
lumen, namely the two structural layers of varying elasticity
(intima-media and adventitia).
The curves may be described as follows:
a) An initial rise in force as the wire wave-guide
contacts the sample.
b) Peak 1: This initial maximum peak force is thought
to represent perforation of the intima-media layer
(samples were set-up so the internal arterial wall
was penetrated, simulating the in vivo scenario).
c) A secondary rise in force as the waveguide contacts
the adventitia layer.
d) Peak 2: Perforation of the adventitia layer and an
associated reduction in force to a negligible value.
It is also possible to see that when the waveguide is not
activated, there is a net reactive force on the waveguide after
perforation due to friction with the tissue. This force appears
to be less in the tests with the ultrasound applied.

Fig. 4. Penetration force profiles, with no ultrasound applied (No US)
and for an ultrasonic wire waveguide distal-tip displacement of 32 µm
peak-to-peak. Waveguide feed-rate = 0.5 mm/s.

The increase in ultrasonic power to the wire waveguide
and therefore increased distal-tip displacements resulted in a
lower force required to perforate both the intima-media layer
and the adventitia. The results of the maximum penetration
force in all 12 experiments are shown in Figure 5.
The average maximum force (Newtons) required for
perforation with ultrasound is approximately 30% (3.96 N

vs. 2.67 N) less than without ultrasound at the lowest
ultrasonic power setting (32µm p-p). With no ultrasound
activation, it was found that a force exceeding 3.8 N resulted
in perforation of the healthy arterial tissue with the 1mm
rounded waveguide distal-tip, while at ultrasonic energy
levels of 80 µm p-p this was reduced to approximately 2 N.

Fig. 5. Maximum penetration force (through intima-media layer) with no
ultrasound applied (No US) and for ultrasonic wire waveguide distal-tip
displacement of 32, 50 and 80 µm peak-to-peak. All 12 tissue tests shown.
Waveguide feed-rate = 0.5 mm/s.

IV. CONCLUSIONS
Chronic total occlusions are associated with increased
complications, including incidence of arterial perforation due
to their geometrical and mechanical composition. As a result,
they often require more aggressive strategies. Therapeutic
ultrasound angioplasty has been shown to be effective in the
removal of fibrous and calcified plaques. Increases in distaltip displacements have also been shown to increase removal
rates of the diseased tissues, particularly calcified plaques.
This study indicates that at the displacements required to
effectively remove diseased tissue, there may be an
associated reduction in the force required to cause
perforation of the healthy arterial wall. For the experiments
outlined above, the angle of incidence of the waveguide is 90
degrees and may not be entirely representative of the in vivo
situation where lower contact angles are more probable from
waveguide deflection off the lumen axis. Also, the diameter
of wire used in this study is greater than those reported in the
literature for arterial access and is, therefore, more rigid.
Incidence of arterial perforation still occur, however, with
highly flexible guidewires and devices and the results
presented here show that with ultrasonic activation the force
required to cause perforation may be reduced further.
These results may prove useful in determining optimum
operating powers for safe selective tissue removal, while
reducing the likelihood of arterial perforation.
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